Janssen Search
Search results
Speech Biomarkers: A New Tool in Alzheimer’s Disease Clinical Trials
Speech Biomarkers: A New Tool in Alzheimer’s Disease Clinical Trials Imagine a world where a recording of a person’s voice could help healthcare professionals more quickly detect a neurological condition. Thanks to efforts across the Clinical ...
Twenty Years of Progress in Search for an HIV Vaccine
Twenty Years of Progress in Search for an HIV Vaccine The world’s inaugural HIV Vaccine Awareness Day (HVAD) was held 20 years ago. HVAD was created in 1998 to commemorate U.S. President Bill Clinton’s declaration that the world needed – and was capable ...
Clinical Trials
How J&J is Prioritizing DE&I in Clinical Trial Design Janssen Global Development Leadership Share Commitment to All Involved in Clinical Research Post-Marketing Requirements Clinical Trials Investigator Databank: Cross-Industry Collaboration ...
TransCelerate Biopharma
Janssen Participates in TransCelerate Biopharma to Accelerate Development of New Medicines Janssen and nine other leading biopharmaceutical companies formed TransCelerate BioPharma Inc. (TransCelerate), a non-profit organization dedicated to improving the ...
Richard (Dick) Insel, M.D.
RICHARD (DICK) INSEL, M.D. GLOBAL HEAD HEALTHY BABY INITIATIVE WORLD WITHOUT DISEASE ACCELERATOR As Global Head, Healthy Baby Initiative, World Without Disease Accelerator (WWDA), Dick is leading a strategy focused on changing the trajectory of health for ...
Contact Pulmonary Hypertension
Contact Pulmonary Hypertension Thank you for your interest in learning more about us. What are you interested in? Collaborations Research & Development Media Inquiries Therapeutic Area or Regional Media Inquiries Employment Opportunities Educational ...
Washington University Research Alliance
Research Alliance Marks Innovative Collaboration in Type 1 Diabetes Article Type: World Without Disease Accelerator Disease Interception Accelerator Cardiovascular & Metabolism Partnerships The Disease Interception Accelerator and Janssen ...
Sanjaya Singh, Ph.D.
SANJAYA SINGH, Ph.D. GLOBAL HEAD JANSSEN BIOTHERAPEUTICS (JBIO) Sanjaya Singh, Ph.D., is the Global Head of Janssen BioTherapeutics, the biotherapeutics engine of Janssen Research & Development. He is responsible for leading an organization of more ...
ASCO GU 2023
Welcome to the Janssen Oncology ASCO GU Virtual Newsroom Luca Dezzani, M.D. U.S. Vice President Medical Affairs, Solid Tumor Janssen Scientific Affairs, LLC Kiran Patel, M.D. Vice President Clinical Development, Solid Tumors Janssen Research & ...
Janssen Signs with Yale Open Data Access
Janssen Signs First-of-its-Kind Agreement With Yale School of Medicine’s Open Data Access Project Janssen Research & Development (R&D) signed a first-of-its-kind agreement with Yale School of Medicine’s Open Data Access (YODA) Project to ...